Stocks Higher as In...
Health Care: Drugs
Hyperion Therapeutics Inc (HPTX: NASDAQ)
$20.66 -0.12 | -0.58%
06/18/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Bought | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 27.63M | 27.23M | 18.34M | 17.48M | 16.60M | 16.85M | 16.83M |
| Shares Bought | 22.31M | 22.05M | 11.83M | 12.47M | 11.59M | 16.62M | 16.59M |
| Shares Sold | 392,546 | 428,008 | 1.08M | 707,623 | 707,623 | 600 | 0 |
Portfolios with HPTX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
Latest HPTX Headlines from TheStreet
- Hyperion Therapeutics Announces RAVICTI And BUPHENYL Pharmacokinetic Analyses Reported In The Journal Of Clinical Pharmacology 06.18.13 | 08:06 am
- Hyperion Therapeutics Enters Oversold Territory (HPTX) 06.04.13 | 12:06 pm
- Hyperion Therapeutics Acquires Worldwide Rights To BUPHENYL 06.03.13 | 09:06 am
- Hyperion Therapeutics To Present At The Jefferies 2013 Global Healthcare Conference 05.29.13 | 04:05 pm
- Hyperion Therapeutics Added To NASDAQ Biotechnology Index (NBI) 05.16.13 | 04:05 pm
- Hyperion Therapeutics Announces First Quarter 2013 Operating Results 05.09.13 | 04:05 pm
- Hyperion Therapeutics To Report First Quarter 2013 Financial Results After Market On May 9, 2013 05.06.13 | 06:05 pm
- Hyperion Therapeutics Receives Orphan Drug Exclusivity From FDA 05.02.13 | 09:05 am
- Hyperion Therapeutics Exercises Option To Acquire Rights To BUPHENYL(R) And AMMONUL(R) 05.02.13 | 09:05 am
- Hyperion Therapeutics Becomes Oversold (HPTX) 05.01.13 | 12:05 pm
Press Releases for HPTX
- Hyperion Therapeutics Completes Initial Public Offering And Announces Exercise Of Underwriters’ Over-Allotment Option - Business Wire 07.31.12 | 04:07 pm
- Hyperion Therapeutics Announces Pricing Of Initial Public Offering - Business Wire 07.26.12 | 08:07 am
Partner Headlines for HPTX
